M
Mercedes C. Becerra
Researcher at Harvard University
Publications - 163
Citations - 7321
Mercedes C. Becerra is an academic researcher from Harvard University. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 39, co-authored 146 publications receiving 6364 citations. Previous affiliations of Mercedes C. Becerra include Partners In Health & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Community-based approaches to HIV treatment in resource-poor settings.
Paul Farmer,Fernet Leandre,Joia S. Mukherjee,Marie Sidonise Claude,Patrice Nevil,Mary C. Smith-Fawzi,Serena P. Koenig,Arachu Castro,Mercedes C. Becerra,Jeffrey D. Sachs,Amir Attaran,Jim Yong Kim +11 more
TL;DR: It is shown that it is possible to carry out an HIV treatment programme in a poor community in rural Haiti, and it is suggested that directly-observed therapy of chronic infectious disease with multidrug regimens can be highly effective in settings of great privation as long as there is sustained commitment to uninterrupted care that is free to the patient.
Journal ArticleDOI
Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients
Shama D. Ahuja,David Ashkin,Monika Avendano,Rita Banerjee,Melissa Bauer,Jamie N. Bayona,Mercedes C. Becerra,Mercedes C. Becerra,Andrea Benedetti,Marcos Burgos,Rosella Centis,Eward D. Chan,Chen Yuan Chiang,Helen Cox,Lia D'Ambrosio,Kathy DeRiemer,Nguyen Huy Dung,Donald A. Enarson,Dennis Falzon,Katherine Flanagan,Jennifer Flood,Maria de Lourdes García-García,Neel R. Gandhi,Reuben Granich,Maria G. Hollm-Delgado,Timothy H. Holtz,Michael D. Iseman,Leah G. Jarlsberg,Salmaan Keshavjee,Hye-Ryoun Kim,Won-Jung Koh,Joey Lancaster,Christophe Lange,Wiel C M de Lange,Vaira Leimane,Chi Chiu Leung,Jiehui Li,Dick Menzies,Giovanni Battista Migliori,Sergey P. Mishustin,Carole D. Mitnick,Masa Narita,Philly O'Riordan,Madhukar Pai,Domingo Palmero,Seung-kyu Park,Geoffrey Pasvol,José María Peña,Carlos Pérez-Guzmán,M. I. D. Quelapio,Alfredo Ponce-de-León,Vija Riekstina,Jérôme Robert,Sarah Royce,H. Simon Schaaf,Kwonjune J. Seung,Lena Shah,Tae Sun Shim,Sonya Shin,Yuji Shiraishi,José Sifuentes-Osornio,Giovanni Sotgiu,Matthew Strand,Payam Tabarsi,Thelma E. Tupasi,Robert van Altena,Martie van der Walt,Tjip S. van der Werf,Mario H. Vargas,Pirett Viiklepp,Janice Westenhouse,Wing Wai Yew,Jae-Joon Yim +72 more
TL;DR: Findings from a collaborative, individual patient-level meta-analysis of treatment outcomes among patients with multidrug-resistant tuberculosis are reported.
Journal ArticleDOI
Community-Based Therapy for Multidrug-Resistant Tuberculosis in Lima, Peru
Carole D. Mitnick,Jaime Bayona,Eda Palacios,Sonya Shin,Jennifer Furin,Felix Alcántara,Epifanio Sánchez,Madeleny Sarria,Mercedes C. Becerra,Mary C. Smith Fawzi,Saidi Kapiga,Donna Neuberg,James H. Maguire,Jim Yong Kim,Paul Farmer +14 more
TL;DR: Community-based outpatient treatment of multidrug-resistant tuberculosis can yield high cure rates even in resource-poor settings and early initiation of appropriate therapy can preserve susceptibility to first-line drugs and improve treatment outcomes.
Journal ArticleDOI
Comprehensive treatment of extensively drug-resistant tuberculosis.
Carole D. Mitnick,Sonya Shin,Kwonjune J. Seung,Michael Rich,Sidney Atwood,Jennifer Furin,Garrett M. Fitzmaurice,Felix A. Alcantara Viru,Sasha C. Appleton,Jaime Bayona,Cesar Bonilla,Katiuska Chalco,Sharon S Choi,Molly F. Franke,Hamish S. F. Fraser,Dalia Guerra,Rocío M. Hurtado,Darius Jazayeri,Keith Joseph,Karim Llaro,Lorena Mestanza,Joia S. Mukherjee,Maribel Muñoz,Eda Palacios,Epifanio Sánchez,Alexander Sloutsky,Mercedes C. Becerra +26 more
TL;DR: Extensively drug-resistant tuberculosis can be cured in HIV-negative patients through outpatient treatment, even in those who have received multiple prior courses of therapy for tuberculosis.
Journal ArticleDOI
Programmes and principles in treatment of multidrug-resistant tuberculosis
Joia S. Mukherjee,Joia S. Mukherjee,Michael Rich,Michael Rich,Adrienne R. Socci,J. Keith Joseph,J. Keith Joseph,Felix A. Alcantara Viru,Sonya Shin,Sonya Shin,Jennifer Furin,Mercedes C. Becerra,Donna Barry,Jim Yong Kim,Jim Yong Kim,Jaime Bayona,Paul Farmer,Paul Farmer,Mary C. Smith Fawzi,Kwonjune J. Seung,Kwonjune J. Seung +20 more
TL;DR: MDR-TB can and should be addressed therapeutically in resource-poor settings; starting of treatment early is crucial; aggressive treatment regimens and high-end dosing are recommended; and strategies to improve treatment adherence, such as directly observed therapy, should be used.